Trial Profile

A single center, exploratory, open-label prospective study using a minimally invasive LysinDAIR procedure in patients with chronic knee prosthetic joint infection (PJI), due to coagulase-negative staphylococci (CoNS)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Sep 2022 New trial record
12 Sep 2022 Results published in the ContraFect Media Release.
12 Sep 2022 According to a ContraFect media release, the results from this study were presented by Dr. Tristan Ferry of the Infectious and Tropical Diseases Unit, Croix-Rousse Hospital, Hospices Civils de Lyon in Lyon, France at the 40th Annual Meeting of the European Bone and Joint Infection Society, held in Graz, Austria from September 8-10, 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com